ArticleClinical pharmacology in drug development2026

Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Luseogliflozin (TS-071) in Japanese Children and Adolescents With Type 2 Diabetes: A Multicenter, Open-Label, Parallel-Group Phase 1 Study.

Toru Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.